Liberum Capital reissued their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research note issued to investors on Thursday, ThisIsMoney.Co.Uk reports.
A number of other analysts have also issued reports on the company. Deutsche Bank reissued a hold rating and issued a GBX 1,775 ($23.19) target price on shares of in a research report on Wednesday, June 26th. UBS Group lowered Telstra from a buy rating to a neutral rating in a research report on Monday, July 1st. Morgan Stanley reissued an overweight rating on shares of in a research report on Thursday, June 20th. Kepler Capital Markets set a €14.00 ($16.28) target price on alstria office REIT and gave the company a neutral rating in a research report on Tuesday, May 7th. Finally, Shore Capital reissued a house stock rating on shares of in a research report on Wednesday, June 12th. Three analysts have rated the stock with a sell rating, four have given a hold rating and twelve have assigned a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of GBX 7,211.11 ($94.23).
Shares of LON RB opened at GBX 6,595 ($86.18) on Thursday. The stock has a market capitalization of $46.76 billion and a price-to-earnings ratio of 21.64. The company has a current ratio of 0.65, a quick ratio of 0.47 and a debt-to-equity ratio of 80.49. Reckitt Benckiser Group has a 52-week low of GBX 5,559 ($72.64) and a 52-week high of GBX 7,174 ($93.74). The firm has a 50 day moving average price of GBX 6,384.22.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Article: What is insider trading?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.